Ani Pharmaceuticals reported $470.45M in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Aerie Pharmaceuticals AERI:US $ 351.8M 3.73M
Ani Pharmaceuticals ANIP:US $ 470.45M 9.7M
Aurora Cannabis Inc ACB:CN 2.56B 44.42M
Biodelivery Sciences International BDSI:US $ 256.07M 5.74M
Canopy Growth Corp WEED:CN C$ 6.49B 475.73M
Depomed DEPO:US $ 299.3M 12.71M
Eli Lilly And LLY:US $ 48187M 378M
Emergent Biosolutions EBS:US $ 2867.5M 47.7M
Endo International Ordinary Shares ENDP:US $ 9246.55M 40.3M
Flexion Therapeutics FLXN:US $ 217.93M 7.88M
Heron Therapeutics HRTX:US $ 352.39M 51.86M
Hikma Pharmaceutical HIK:LN 4.18B 45M
Knight Therapeutics Inc GUD:CN C$ 1.04B 6.03M
Lannett LCI:US $ 690.87M 7.13M
Nektar Therapeutics NKTR:US $ 1277.24M 94.11M
Novartis NVS:US $ 121209M 2806M
Omeros OMER:US $ 123.43M 21.96M
Perrigo Ordinary Shares PRGO:US $ 10915.9M 314.4M
Teva Pharmaceutical TEVA:IT 47.85B 1.34B
Teva Pharmaceutical Industries TEVA:US $ 47851M 1344M